Biotech & Pharma
Altimmune Inc is a United States-based clinical stage immunotherapeutic biotechnology company. It is involved in the business of developing products that engage, stimulate and improve immune responses for the prevention and treatment of diseases. The firm's product candidates include NasoVAX, HepTcell, SparVax-L, NasoShield, and Oncosyn. It also develops platform technologies such as RespirVec and Densigen. The company generates its revenue from cost plus fee contracts and fixed-price contracts.
Earnings Per Share (EPS)
Price To Earnings Ratio (P/E)
1st Quarter Earnings Report
for Jan, Feb & Mar
Wed, May 15, 2019 (205 days ago)
Since Earnings Report -28.5%
2nd Quarter Earnings Report
for Apr, May & Jun
Wed, Aug 14, 2019 (114 days ago)
Since Earnings Report -11.3%
Annual Dividend Yield
Annual Dividend Rate
Fri, Dec 21, 2018 (350 days ago)
Dividend Pay Date
Mon, Dec 31, 2018
99 Payments (Biannual)
All Time High $2,100.00 Wed, Aug 8, 2007
|BIOTECH & PHARMA|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.